CarMax Under Investigation for Allegedly Misleading Investors
CarMax, Inc. (NYSE:KMX) is facing an investigation by the law firm Faruqi & Faruqi, LLP regarding allegations that the used vehicle retailer misled investors about its growth prospects and business operations.
The investigation focuses on claims that CarMax's growth in fiscal 2026 was temporarily boosted by unsustainable customer speculation on tariffs, which allegedly led to misleading statements. This scrutiny follows the company's second-quarter financial report for fiscal 2026, which disclosed a significant downturn in its finance division.
The company reported an 11.2% decrease in income from its CarMax Auto Finance (CAF) segment. This was driven by a $142.2 million provision for loan losses, a notable increase from the $112.6 million provisioned in the same period of the previous year.
In response to the financial disclosure, CarMax's stock price dropped by approximately 20%, closing at $45.60 on September 26, 2025. A class-action lawsuit has been initiated, and investors who suffered losses between June 20, 2025, and September 24, 2025, have a deadline of January 2, 2026, to apply for the lead plaintiff position.
Reflecting a bearish outlook, Evercore ISI maintained a Reduce rating for CarMax on November 6, 2025, while Benchmark downgraded the stock to a Hold rating. The stock is currently trading at $34.20.
CarMax, Inc. (KMX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.